The binding of the antibody to this region activates extracellular ERK and JNK pathways, leading to the activation of NF-κB and production of TNF-α which further increases csGRP78 expression in RA-FLS, which unlike the mechanisms observed in cancer, leads the RA cells to apoptosis. Here, NFKB1 is linked to cancer.